RT Book, Section
A1 Kitagawa, Yuko
A1 Dempsey, Daniel T.
A2 Brunicardi, F. Charles
A2 Andersen, Dana K.
A2 Billiar, Timothy R.
A2 Dunn, David L.
A2 Hunter, John G.
A2 Matthews, Jeffrey B.
A2 Pollock, Raphael E.
SR Print(0)
ID 1117748233
T1 Stomach
T2 Schwartz's Principles of Surgery, 10e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071796743
LK accessmedicine.mhmedical.com/content.aspx?aid=1117748233
RD 2024/04/18
AB Any  patient  admitted  to  a  hospital  because  of  peptic  ulcer  disease  should  be  considered  for  lifelong  acid  suppression.Lifelong  acid  suppressive  medication  may  be  equivalent  to  surgical  vagotomy  in  preventing  recurrent  peptic  ulcer  or  ulcer  complications.Roux-en-Y  gastrojejunostomy  should  be  avoided  unless  more  than  half  of  the  stomach  has  been  removed.  Otherwise  marginal  ulceration  and/or  gastric  stasis  (Roux  syndrome)  may  become  problematic.Gastric  resection  for  peptic  ulcer  should  be  avoided  in  the  asthenic  or  high-risk  patient,  if  possible.Many  patients  with  locally  advanced  gastric  cancer  (T2b,  T3,  T4)  are  cured  by  an  oncologically  sound  operation  that  includes  wide  margins  and  adequate  lymphadenectomy.Most  patients  with  primary  gastric  lymphoma  can  be  treated  without  gastric  resection.Gastric  carcinoids  should  usually  be  removed  either  endoscopically  or  surgically.  The  surgeon  should  treat  gastric  carcinoid  without  hypergastrinemia  (type  III)  as  if  it  were  malignant.